Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:447 (23 February), doi:10.1136/bmj.39364.672940.47
Niamh OCarroll, clinical teaching fellow1, John Fitzsimons, specialist registrar in respiratory paediatrics2, Siobhán Carr, consultant in respiratory paediatrics2
1 Department of Primary Care and Social Medicine, Imperial College Faculty of Medicine, London W6 8RP, 2 Barts and the London Childrens Hospital, London E1 1BB
Correspondence to: N OCarroll n.ocarroll@imperial.ac.uk
| The first 150 words of the full text of this article appear below. |
A 7 year old boy with recurrent wheeze was diagnosed with asthma six months ago. He was started on two metered dose inhalers: a short acting β2 agonist, as required, and an inhaled corticosteroid 100 µg (beclometasone diproprionate equivalent) twice daily. When his symptoms continued his steroid inhaler was increased to 200 µg twice daily, but he presents to the surgery with regular wheeze.
Assess control of wheeze, cough, nights disturbed, absence from school, and interference with play or exercise. Assess frequency of use of short acting β2 agonists and courses of oral steroids. Ask about emergency consultations or hospital attendances and possible triggers, especially smoking and common allergens such as dust mite, pet dander, and pollens, as well as viral infections, exercise, cold air, emotional upset, and non-steroidal anti-inflammatory drugs. Ask about school: can he use the inhalers with the spacer device, and can he take his β2 agonist
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses